[Questionnaire results on implantable catheter systems].
Recent advance of intra-arterial chemotherapy can be attributed to improvement of devices, especially implantable catheter systems. In May 1989, a questionnaire was set out through the Japanese Association of Arterial Cancer Chemotherapy to find out the current use of arterial as well as intravenous implantable systems. The results revealed that: 1) Arterial implantable systems were widely used in 1879 patients at 91 institutes, mainly to treat patients with primary and secondary liver cancers. Intravenous systems were used in 88 patients at 17 institutes. 2) Implantable catheter systems were used for long-term intermittent or continuous infusion. 3) Compared with percutaneous catheters, a decrease in infection and occlusion rates and less daily care were noted. 4) Due to the development of implantable systems, 890 out of 1,879 patients on arterial therapy and 60 out of 88 patients on intravenous therapy could switch over to an outpatient basis. 5) Improvement of "quality of life" was found at all but one institute. 6) All questionnaires (except unanswered) requested health insurance reimbursement for totally implantable catheter systems.
Taguchi
T
T
Dept. of Oncologic Surgery, Osaka University.
D000970:Antineoplastic Agents / Q000008:administration & dosage*; D006801:Humans; D007260:Infusion Pumps / Q000706:statistics & numerical data*; D007261:Infusions, Intra-Arterial; D007262:Infusions, Intravenous; D007564:Japan; D011795:Surveys and Questionnaires
D000970:Antineoplastic Agents